Express Scripts Holding Co.’s incoming CEO is trying to keep its biggest customer after Anthem Inc. sued to recoup billions of dollars in what it called excess payments for drugs and threatened to end their relationship.
Pharmacists in Indiana will be able to limit how much cold medicine customers can buy under a measure Indiana Gov. Mike Pence signed into law Monday.
The insurer’s CEO said in January that Anthem should be reaping an addition $3 billion per year in savings on drugs from Express Scripts, which manages its pharmacy benefits.
Two measures aimed at to reducing methamphetamine production in Indiana are on their way to the governor's desk after receiving approval from the full House.
The erectile-dysfunction drug, made famous by a slew of quirky commercials, is facing performance issues of its own.
Teva’s acquisition will make it the world’s largest maker of generic medicines, giving it greater negotiating power with governments and private-health insurers.
Bills would let pharmacists require prescriptions for suspicious customers trying to buy cold medicines with pseudoephedrine. But some drug store chains fear putting their pharmacists in danger.
The supermarket chain will make naloxone available in its pharmacies across Ohio and northern Kentucky, a region hard-hit by deadly heroin.
The new version of the Indiana bill would classify pseudoephedrine in a way that most consumers would be able to buy it, but pharmacists could require a prescription from suspicious customers.
Indiana pharmacists could get the legal right to refuse to sell a common cold medicine used to make methamphetamine to suspicious customers under a bill a Senate committee approved Tuesday.
Indianapolis-based Eli Lilly and Co., which has promised to return to growth after a half-decade of falling revenue, indicated that 2016 earnings might be below analysts’ estimates.
The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags.
A professor in the Indiana School of Medicine is hopeful that an antibiotic cocktail he invented will one day improve the lives of millions of people, thanks in part to the Indiana University Research and Technology Corp., formed in 1997 to make work done by IU faculty and researchers available for commercial development.
The companies will work on coupling therapies from Lilly with technology from Halozyme Therapeutics that helps the body disperse and spread medicine.
The FDA said Wednesday it approved Basaglar based on data showing it is safe and effective and works similarly to Lantus, the world’s top-selling insulin.
A new study says women who took a common class of antidepressants during the second and third trimesters were more than twice as likely than other women to have children who later developed autism.
Eli Lilly said Friday that it decided to stop developing the insulin peglispro after learning that it would take more time and cost more than expected to understand a significant side effect.
With time running out on open-enrollment season, many seniors are facing sharply higher costs for Medicare's popular prescription drug program after a long stretch of stable premiums.
It's also the largest so-called inversion, where an American corporation combines with a company headquartered in a country with a lower corporate tax rate, saving potentially millions each year in U.S. taxes.
In a vote Tuesday, the American Medical Association called for an end to television commercials and magazine spreads that are used to pitch prescription drugs directly to consumers.
